Table 5 Statistical comparisons between patients with and without PTDM
Characteristic | Missing | PTDM* | p-value¥ | |
|---|---|---|---|---|
No N = 205 | Yes N = 42 | |||
Age | 38.1 ± 14.2 | 46.7 ± 14.9 | < 0.001 | |
Pre-transplantation BMI | 0 (0.0%) | 0.278 | ||
< 18.5 | 21 (10.2%) | 4 (9.5%) | ||
18.5–24.9 | 90 (43.9%) | 12 (28.6%) | ||
25–29.9 | 58 (28.3%) | 14 (33.3%) | ||
30–34.9 | 29 (14.1%) | 10 (23.8%) | ||
35 or more | 7 (3.4%) | 2 (4.8%) | ||
Post-transplantation BMI | 0 (0.0%) | 0.840 | ||
< 18.5 | 16 (7.8%) | 2 (4.8%) | ||
18.5–24.9 | 58 (28.3%) | 10 (23.8%) | ||
25–29.9 | 73 (35.6%) | 15 (35.7%) | ||
30–34.9 | 41 (20.0%) | 10 (23.8%) | ||
35 or more | 17 (8.3%) | 5 (11.9%) | ||
Fasting glucose at 6 months (mmol/L) | 19 (7.7%) | 5.3 ± 0.8 | 7.1 ± 2.5 | < 0.001 |
Fasting glucose at 12 months (mmol/L) | 12 (4.9%) | 5.3 ± 0.8 | 7.8 ± 3.6 | < 0.001 |
Serum Creatinine at time of discharge (µmmol/L) | 95.6 ± 39.8 | 84.3 ± 26.5 | 0.222 | |
Serum Creatinine at 12 months (µmmol/L) | 89.6 ± 23.2 | 87.4 ± 22.3 | 0.449 | |